278 related articles for article (PubMed ID: 30503823)
21. CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.
Schneidawind D; Pierini A; Alvarez M; Pan Y; Baker J; Buechele C; Luong RH; Meyer EH; Negrin RS
Blood; 2014 Nov; 124(22):3320-8. PubMed ID: 25293774
[TBL] [Abstract][Full Text] [Related]
22. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia.
Liu R; La Cava A; Bai XF; Jee Y; Price M; Campagnolo DI; Christadoss P; Vollmer TL; Van Kaer L; Shi FD
J Immunol; 2005 Dec; 175(12):7898-904. PubMed ID: 16339525
[TBL] [Abstract][Full Text] [Related]
23. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.
Zheng Q; Xu Y; Liu Y; Zhang B; Li X; Guo F; Zhao Y
J Mol Med (Berl); 2009 Dec; 87(12):1191-205. PubMed ID: 19841877
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic and transcriptional analysis supports human regulatory T cell commitment at the CD4+CD8+ thymocyte stage.
Vanhanen R; Leskinen K; Mattila IP; Saavalainen P; Arstila TP
Cell Immunol; 2020 Jan; 347():104026. PubMed ID: 31843201
[TBL] [Abstract][Full Text] [Related]
25. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
26. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
[TBL] [Abstract][Full Text] [Related]
27. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
28. Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
Petersen TR; Sika-Paotonu D; Knight DA; Dickgreber N; Farrand KJ; Ronchese F; Hermans IF
Immunol Cell Biol; 2010 Jul; 88(5):596-604. PubMed ID: 20142835
[TBL] [Abstract][Full Text] [Related]
29. G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo.
Hansen W; Loser K; Westendorf AM; Bruder D; Pfoertner S; Siewert C; Huehn J; Beissert S; Buer J
J Immunol; 2006 Jul; 177(1):209-15. PubMed ID: 16785516
[TBL] [Abstract][Full Text] [Related]
30. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
31. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
Gorczynski RM
Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4
Hall BM; Hall RM; Tran GT; Robinson CM; Wilcox PL; Rakesh PK; Wang C; Sharland AF; Verma ND; Hodgkinson SJ
Front Immunol; 2021; 12():714838. PubMed ID: 34912327
[TBL] [Abstract][Full Text] [Related]
33. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
34. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
35. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis.
Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712
[TBL] [Abstract][Full Text] [Related]
36. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
[TBL] [Abstract][Full Text] [Related]
37. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.
Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y
Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256
[TBL] [Abstract][Full Text] [Related]
38. Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells.
Marguti I; Yamamoto GL; da Costa TB; Rizzo LV; de Moraes LV
Immunology; 2009 May; 127(1):50-61. PubMed ID: 18778287
[TBL] [Abstract][Full Text] [Related]
39. Depletion of thymus-derived CD4+CD25+ T cells abrogates the suppressive effects of alpha-galactosylceramide treatment on experimental allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Ueno H; Taguchi O
Allergol Int; 2008 Sep; 57(3):241-6. PubMed ID: 18493168
[TBL] [Abstract][Full Text] [Related]
40. An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4(+)Foxp3(+) Treg cells.
Liu G; Duan K; Ma H; Niu Z; Peng J; Zhao Y
Immunol Cell Biol; 2011 Nov; 89(8):827-35. PubMed ID: 21844881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
